Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220888941> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W4220888941 endingPage "e276" @default.
- W4220888941 startingPage "e274" @default.
- W4220888941 abstract "Dear Editor, Large-vessel vasculitis (LVV) typically refers to the inflammatory disease of large blood vessels, predominantly affecting the aorta and its major branches. LVV is classified into two major categories: Takayasu arteritis (TAK) and GCA. The therapeutic mainstay in TAK and GCA is high-dose glucocorticoid therapy. Although immunosuppressants such as methotrexate, azathioprine and mycophenolate mofetil and biologics including anti-TNF-α antibodies, tocilizumab and abatacept are used in refractory LVV cases [1], progressive diseases manifesting as vascular stenosis and occlusion due to sustained inflammation of vessel walls are sometimes observed despite adequate anti-inflammatory treatment, especially in TAK [2, 3]. Therefore, developing new treatment alternatives is an important issue in LVV. Recently, refractory TAK cases successfully treated with tofacitinib, a Janus kinase (JAK) inhibitor, have been reported [2, 3]. However, there are few reports for the clinical effectiveness of other JAK inhibitors except tofacitinib in LVV, especially GCA. Just one successful case was demonstrated regarding the efficacy of baricitinib in a patient with relapsing GCA [4]. We here report a case of GCA concomitant with PsA successfully treated with upadacitinib, a selective JAK1 inhibitor, inducing and maintaining remission without any disease progression in imaging analyses by the combined use of glucocorticoid." @default.
- W4220888941 created "2022-04-03" @default.
- W4220888941 creator A5016907214 @default.
- W4220888941 creator A5035085923 @default.
- W4220888941 creator A5082925324 @default.
- W4220888941 creator A5085246080 @default.
- W4220888941 date "2022-03-31" @default.
- W4220888941 modified "2023-09-29" @default.
- W4220888941 title "Therapeutic effectiveness of upadacitinib combined with glucocorticoid on remission induction and maintenance in giant cell arteritis" @default.
- W4220888941 cites W1964525131 @default.
- W4220888941 cites W2737436316 @default.
- W4220888941 cites W2779326947 @default.
- W4220888941 cites W3013180209 @default.
- W4220888941 cites W3037926703 @default.
- W4220888941 cites W3125428760 @default.
- W4220888941 cites W3206093525 @default.
- W4220888941 doi "https://doi.org/10.1093/rheumatology/keac203" @default.
- W4220888941 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35357433" @default.
- W4220888941 hasPublicationYear "2022" @default.
- W4220888941 type Work @default.
- W4220888941 citedByCount "3" @default.
- W4220888941 countsByYear W42208889412022 @default.
- W4220888941 countsByYear W42208889412023 @default.
- W4220888941 crossrefType "journal-article" @default.
- W4220888941 hasAuthorship W4220888941A5016907214 @default.
- W4220888941 hasAuthorship W4220888941A5035085923 @default.
- W4220888941 hasAuthorship W4220888941A5082925324 @default.
- W4220888941 hasAuthorship W4220888941A5085246080 @default.
- W4220888941 hasConcept C126322002 @default.
- W4220888941 hasConcept C141071460 @default.
- W4220888941 hasConcept C2776015282 @default.
- W4220888941 hasConcept C2776712624 @default.
- W4220888941 hasConcept C2776760755 @default.
- W4220888941 hasConcept C2777178219 @default.
- W4220888941 hasConcept C2777575956 @default.
- W4220888941 hasConcept C2778886723 @default.
- W4220888941 hasConcept C2779134260 @default.
- W4220888941 hasConcept C2779338263 @default.
- W4220888941 hasConcept C2779605438 @default.
- W4220888941 hasConcept C2780079024 @default.
- W4220888941 hasConcept C2780132546 @default.
- W4220888941 hasConcept C2780653079 @default.
- W4220888941 hasConcept C2780841215 @default.
- W4220888941 hasConcept C2781059491 @default.
- W4220888941 hasConcept C71924100 @default.
- W4220888941 hasConcept C90924648 @default.
- W4220888941 hasConceptScore W4220888941C126322002 @default.
- W4220888941 hasConceptScore W4220888941C141071460 @default.
- W4220888941 hasConceptScore W4220888941C2776015282 @default.
- W4220888941 hasConceptScore W4220888941C2776712624 @default.
- W4220888941 hasConceptScore W4220888941C2776760755 @default.
- W4220888941 hasConceptScore W4220888941C2777178219 @default.
- W4220888941 hasConceptScore W4220888941C2777575956 @default.
- W4220888941 hasConceptScore W4220888941C2778886723 @default.
- W4220888941 hasConceptScore W4220888941C2779134260 @default.
- W4220888941 hasConceptScore W4220888941C2779338263 @default.
- W4220888941 hasConceptScore W4220888941C2779605438 @default.
- W4220888941 hasConceptScore W4220888941C2780079024 @default.
- W4220888941 hasConceptScore W4220888941C2780132546 @default.
- W4220888941 hasConceptScore W4220888941C2780653079 @default.
- W4220888941 hasConceptScore W4220888941C2780841215 @default.
- W4220888941 hasConceptScore W4220888941C2781059491 @default.
- W4220888941 hasConceptScore W4220888941C71924100 @default.
- W4220888941 hasConceptScore W4220888941C90924648 @default.
- W4220888941 hasIssue "9" @default.
- W4220888941 hasLocation W42208889411 @default.
- W4220888941 hasLocation W42208889412 @default.
- W4220888941 hasOpenAccess W4220888941 @default.
- W4220888941 hasPrimaryLocation W42208889411 @default.
- W4220888941 hasRelatedWork W11739056 @default.
- W4220888941 hasRelatedWork W2066042126 @default.
- W4220888941 hasRelatedWork W2328396489 @default.
- W4220888941 hasRelatedWork W2329967385 @default.
- W4220888941 hasRelatedWork W2404059674 @default.
- W4220888941 hasRelatedWork W2477188382 @default.
- W4220888941 hasRelatedWork W2998629719 @default.
- W4220888941 hasRelatedWork W3016644375 @default.
- W4220888941 hasRelatedWork W3203151385 @default.
- W4220888941 hasRelatedWork W4206752617 @default.
- W4220888941 hasVolume "61" @default.
- W4220888941 isParatext "false" @default.
- W4220888941 isRetracted "false" @default.
- W4220888941 workType "article" @default.